Figure 3
Figure 3. Agrin deficiency impairs monocytic cell maturation. (A) Representative flow cytometric analysis of the myeloid hematopoietic progenitors in control and agrin-deficient mice and relative frequencies among total BM cells (ctrl, n = 20; Musk-L;Agrn−/−, n = 5). FACS analysis is referred to the Lin−/IL7R−/cKit+/Sca1− gate, in which CMPs are defined as CD34+/low/CD16/32int, whereas GMPs as CD34+/CD16/32+. Equal numbers of sorted CMP(B) or GMP BM progenitors (C) and (E) or CD31+/Lin− BM monoblasts (D) from P5 control and Musk-L;Agrn−/− mice were cultured for 7 (B-C,E) or 5 days (D) with 50 ng/mL recombinant M-CSF (B-C,D) or with 20 ng/mL recombinant G-CSF (E) and total cell numbers relative to control were calculated. Data are from 2 (B-C,E) or 3 (D) independent experiments. Gate strategy was performed as shown in representative plots; R1: c-Kit+/CD31high/Ly6C−/Ly6G−; R2: c-Kit+/CD31+/Ly6C+/Ly6G−; R3: c-Kitlow/CD31−/Ly6Chigh/Ly6G−;R4: c-Kitlow/CD31−/Ly6Cint/Ly6G+. (F) Equal numbers of sorted Ly6Chigh BM cells from P5 control and Musk-L;Agrn−/− mice were cultured for 3 days with 50 ng/mL recombinant M-CSF and total monocytic cell numbers relative to control were calculated. Shown are a representative flow cytometric analysis of Ly6ChighF4/80− (monocytes), Ly-6ChighF4/80+ (monocytes in the process of differentiating into macrophages), and Ly6CloF4/80+ (mature macrophages) and the statistical analysis of the frequency of the 3 populations, (ctrl, n = 14; Musk-L;Agrn−/−, n = 7). (G) Annexin V analysis on P5 BM monocytes and splenic macrophages (ctrl, n = 10; Musk-L;Agrn−/−, n = 7;). In all panels, error bars represent SEM and *P ≤ .05, **P ≤ .01, ***P ≤ .0001.

Agrin deficiency impairs monocytic cell maturation. (A) Representative flow cytometric analysis of the myeloid hematopoietic progenitors in control and agrin-deficient mice and relative frequencies among total BM cells (ctrl, n = 20; Musk-L;Agrn−/−, n = 5). FACS analysis is referred to the Lin/IL7R/cKit+/Sca1 gate, in which CMPs are defined as CD34+/low/CD16/32int, whereas GMPs as CD34+/CD16/32+. Equal numbers of sorted CMP(B) or GMP BM progenitors (C) and (E) or CD31+/Lin BM monoblasts (D) from P5 control and Musk-L;Agrn−/− mice were cultured for 7 (B-C,E) or 5 days (D) with 50 ng/mL recombinant M-CSF (B-C,D) or with 20 ng/mL recombinant G-CSF (E) and total cell numbers relative to control were calculated. Data are from 2 (B-C,E) or 3 (D) independent experiments. Gate strategy was performed as shown in representative plots; R1: c-Kit+/CD31high/Ly6C/Ly6G; R2: c-Kit+/CD31+/Ly6C+/Ly6G; R3: c-Kitlow/CD31/Ly6Chigh/Ly6G;R4: c-Kitlow/CD31/Ly6Cint/Ly6G+. (F) Equal numbers of sorted Ly6Chigh BM cells from P5 control and Musk-L;Agrn−/− mice were cultured for 3 days with 50 ng/mL recombinant M-CSF and total monocytic cell numbers relative to control were calculated. Shown are a representative flow cytometric analysis of Ly6ChighF4/80 (monocytes), Ly-6ChighF4/80+ (monocytes in the process of differentiating into macrophages), and Ly6CloF4/80+ (mature macrophages) and the statistical analysis of the frequency of the 3 populations, (ctrl, n = 14; Musk-L;Agrn−/−, n = 7). (G) Annexin V analysis on P5 BM monocytes and splenic macrophages (ctrl, n = 10; Musk-L;Agrn−/−, n = 7;). In all panels, error bars represent SEM and *P ≤ .05, **P ≤ .01, ***P ≤ .0001.

Close Modal

or Create an Account

Close Modal
Close Modal